Zhongnan Medical Journal Press

Home Results

A total of 25 result was found. Results that relate to Liver injury

Clinical pharmacist participated in a case study of a severe immune-related cholestatic liver injury case induced by camrelizumab

Published on Chinese Journal of Pharmacoepidemiology 2025,34(3):341-345.
14451 times 2337 times

YUWEN Lixia HE Yunhao YUAN Yaohui

Clinical pharmacist Camrelizumab Liver injury Cholestatic Immunotherapy
Details
Clinical characteristics of liver injury induced by different types of drugs and Logistic analysis of the influencing factors on the prognosis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):410-418.
18869 times 4888 times

ZHANG Yafei CAO Yi WANG Zhihao WANG Yuanyuan

Drug-induced liver injury Clinical characteristics Medication history Prognosis analysis Influencing factors
Details
Research progress of mitochondrial dysfunction in drug-induced liver injury

Published on New Medicine 2025,35(5):579-587.
17062 times 2391 times

SUN Huijuan HU Wenkai LIU Shumin

Mitochondrial dysfunction Drug-induced liver injury Mechanism Influencing factors
Details
Drug-induced liver injury caused by enoxaparin: a case report

Published on Journal of Mathematical Medicine 2025,38(6):473-477.
13472 times 2162 times

LIANG Chunpo TIAN Danli

Enoxaparin Drug-induced liver injury Aminotransferase Adverse drug reaction
Details
Development and validation of an XGBoost-based prediction model for acute liver injury in statin users

Published on Chinese Journal of Pharmacoepidemiology 2025,34(8):867-876.
9571 times 2311 times

MENG Xianglong YU Yuelin SUN Yexiang SHEN Peng JIANG Zhiqin ZHU Yu YIN Yueqi ZHAN Siyan WANG Shengfeng

Statins Acute liver injury Prediction model XGBoost algorithm Cost-sensitive learning
Details
Mechanism of agiophyllum oligo saccharides in improving type 2 diabetes mellitus related liver injury based on proteomics method

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1261-1270.
8713 times 1813 times

ZHANG Zihan ZHANG Xiaojie YANG Yuze YANG Tianshuo XING Dongyang MA Qianqian BAO Shuyin

Agiophyllum oligo saccharides Type 2 diabetes mellitus Liver injury Proteomics
Details
Analysis of the occurrence and related factors of drug-induced liver injury in postoperative analgesia with propacetamol

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1252-1257.
9548 times 2006 times

JIN Lei SHEN Yanlin LI Min WANG Fang LI Ping Ge Youting YAO Huijuan

Propacetamol Drug-induced liver injury Adverse drug reactions Risk factors
Details
Effect of regulating miR-29b-3p/FoxO3 axis by asiaticoside on alleviating liver injury in rats with non-alcoholic fatty liver disease

Published on New Medicine 2025,35(10):1165-1172.
7042 times 1568 times

TAN Jie LIU Meng TIAN Xia HAN Zheng ZHU Qingxi ZHAN Ting CHEN Mingtao CHEN Aifang HUANG Min

Asiaticoside Non-alcoholic fatty liver disease Liver injury MicroRNA-29b-3p/forkhead box O3
Details
Acute drug-induced liver injury associated with tolvaptan in a patient with cardiac amyloidosis: a case report

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1347-1352.
8468 times 1619 times

YAO Tingyi ZHANG Weixia

Tolvaptan Drug-induced liver injury AL cardiac amyloidosis Heart failure
Details
Analysis of influencing factors and predictive model construction of anti-tuberculosis drug-induced liver injury

Published on New Medicine 2025,35(12):1413-1420.
10530 times 1443 times

GU Zhengtai LIU Weiwei GU Lingyun MA Chenbin

Tuberculosis Anti-tuberculosis drug-induced liver injury Influencing factors Nomogram
Details